A new model for 5-year risk of cardiovascular disease in Type1 diabetes; from the Swedish National Diabetes Register (NDR)

Diabetic Medicine

Volumn 28, Issue 10, 2011, Pages 1213-1220

  Cederholm, J ^a   Eeg Olofsson, K ^b   Eliasson, B ^b   Zethelius, B ^a   Gudbjornsdottir S ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiovascular diseases; Diabetes; Macrovascular disease; Modelling; Register

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; ONSET AGE; SENSITIVITY AND SPECIFICITY; SMOKING; SYSTOLIC BLOOD PRESSURE;

ADULT; AGE OF ONSET; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SWEDEN;

EID: 80053048355     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03342.x     Document Type: Article

References (24)

1. Stevens RJ, Kothari V, Adler AI, Stratton IM, Holman RR. The UKPDS Risk Engine: a model for the risk of coronary heart disease in typeII diabetes (UKPDS56). Clin Sci 2001; 101: 671-679.
2. Kothari V, Stevens RJ, Adler AI, Stratton IM, Neil HA, Holman RR et al., UK Prospective Diabetes Study Group UKPDS60: risk of stroke in type2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke 2002; 33: 1776-1781.
3. Coleman R, Stevens R, Holman R. The Oxford Risk Engine: a cardiovascular risk calculator for individuals with or without type2 diabetes. Diabetes 2007; 56: A170.
4. Anderson KM, Odell PM, Wilson PWF, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1991; 121: 293-298.
5. D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Kannel WB et al. General cardiovascular risk profile for use in primary care. The Framingham Heart Study. Circulation 2008; 117: 743-753.
6. Cederholm J, Eeg-Olofsson K, Eliasson B, Zethelius B, Nilsson PM, Gudbjörnsdottir S. Risk prediction of cardiovascular disease in type2 diabetes: a risk equation from the Swedish National Diabetes Register. Diabetes Care 2008; 31: 2038-2043.
7. Yang X, So W-Y, Kong APS, Ma RCV, Ko GTC, Tong PCY et al. Development and validation of a total coronary heart disease risk score in Type2 diabetes mellitus. Am J Cardiol 2008; 101: 596-601.
8. Conroy RM, Pyörälä K, De Backer G, De Bacquer D, Wilhelmsen L, Graham IM, SCORE Project Group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003.
9. Ferrario M, Chiodini P, Chambless LE, Cesana G, Vanuzzo D, Panico S et al. Prediction of coronary events in a low incidence population: assessing accuracy of the CUORE Cohort Study prediction equation. Int J Epidemiol 2005; 34: 413-421.
10. Elley CR, Robinson E, Kenealy T, Bramley D, Drury PL. Derivation and validation of a new cardiovascular risk score for people with Type2 diabetes. The New Zealand Diabetes Cohort Study. Diabetes Care 2010; 33: 1347-1352.
11. Jackson R. Cardiovascular risk prediction: are we there yet? Heart 2008; 94: 1-3.
12. Gudbjörnsdottir S, Cederholm J, Nilsson PM, Eliasson B. The National Diabetes Register in Sweden: an implementation of the St Vincent Declaration for Quality Improvement in Diabetes Care. Diabetes Care 2003; 26: 1270-1276.
13. 1c and blood pressure on cardiovascular diseases in type2 diabetes: an observational study from the Swedish National Diabetes Register (NDR). Diabetes Res Clin Pract 2009; 86: 74-81.
14. Cederholm J, Gudbjörnsdottir S, Eliasson B, Zethelius B, Eeg-Olofsson K, Nilsson PM, on behalf of the NDR. Systolic blood pressure and risk of cardiovascular diseases in type2 diabetes: an observational study from the Swedish National Diabetes Register (NDR). J Hypert 2010; 28: 2026-2035.
15. Eeg-Olofsson K, Cederholm J, Nilsson PM, Gudbjörnsdottir S, Eliasson B. Glycemic and risk factor control in type1 diabetes: results from 13612 patients in a national diabetes register. Diabetes Care 2007; 30: 496-502.
16. Eeg-Olofsson K, Cederholm J, Nilsson PM, Zethelius B, Gudbjörnsdóttir S, Eliasson B et al. Glycemic control and cardiovascular disease in 7454 patients with type1 diabetes: an observational study from the Swedish National Diabetes Register (NDR). Diabetes Care 2010; 33: 1640-1646.
17. 1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 2004; 50: 166-174.
18. 1c and the designated comparison methods in the United States, Japan and Sweden. Clin Chem 2008; 54: 1379-1385.
19. Merlo J, Lindblad U, Pessah-Rasmussen H, Hedblad B, Rastam J, Isacsson SO et al. Comparison of different procedures to identify probable cases of myocardial infarction and stroke in two Swedish prospective cohort studies using local and national routine registers. Eur J Epidemiol 2000; 16: 235-243.
20. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994; 90: 583-612.
21. McGeechan K, Macaskill P, Irwig L, Liew G, Wong TY. Assessing new biomarkers and predictive models for use in clinical practice. A clinician's guide. Arch Intern Med 2008; 168: 2304-2310.
22. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007; 115: 928-935.
23. NICE. Management of Type2 Diabetes: Management of Blood Pressure and Blood Lipids. GuidelineH. London: National Institute for Health and Clinical Excellence, 2002.
24. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type2 diabetes. N Engl J Med 2008; 358: 580-591.